Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Aylward, Elizabeth H. | Harrington, Deborah L.; | Mills, James A. | Nopoulos, Peggy C. | Ross, Christopher A. | Long, Jeffrey D. | Liu, Dawei | Westervelt, Holly K. | Paulsen, Jane S. | the PREDICT-HD Investigators and Coordinators of the Huntington Study Group
Affiliations: Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA | Department of Radiology, University of California, San Diego, La Jolla, CA, USA | VA San Diego Healthcare System, Research Service, San Diego, CA, USA | Department of Psychiatry, The University of Iowa Carver College of Medicine, Iowa City, IA, USA | Departments of Psychiatry, Neurology and Neuroscience, Johns Hopkins University, Baltimore, MD, USA | Division of Biology and Medicine, Department of Psychiatry and Human Behavior, Brown University, Providence, RI, USA | Departments of Psychiatry, Neurology, Psychology and Neuroscience, The University of Iowa Carver College of Medicine, Iowa City, IA, USA
Note: [] Correspondence to: Jane S. Paulsen, Ph.D., The University of Iowa, 1-305 MEB, Iowa City, IA 52242, USA. Tel.: +1 319 353 4551; Fax: +1 319 353 4438; E-mail: predict-publications@uiowa.edu
Abstract: Background: Neuroimaging studies suggest that volumetric MRI measures of specific brain structures may serve as excellent biomarkers in future clinical trials of Huntington disease (HD). Objective: Demonstration of the clinical significance of these measures is an important step in determining their appropriateness as potential outcome measures. Methods: Measures of gray- and white-matter lobular volumes and subcortical volumes (caudate, putamen, globus pallidus, thalamus, nucleus accumbens, hippocampus) were obtained from MRI scans of 516 individuals who tested positive for the HD gene expansion, but were not yet exhibiting signs or symptoms severe enough to warrant diagnosis (“pre-HD”). MRI volumes (corrected for intracranial volume) were correlated with cognitive, motor, psychiatric, and functional measures known to be sensitive to subtle changes in pre-HD. Results: Caudate, putamen, and globus pallidus volumes consistently correlated with cognitive and motor, but not psychiatric or functional measures in pre-HD. Volumes of white matter, nucleus accumbens, and thalamus, but not cortical gray matter, also correlated with some of the motor and cognitive measures. Conclusions: Results of regression analyses suggest that volumes of basal ganglia structures contributed more highly to the prediction of most motor and cognitive variables than volumes of other brain regions. These results support the use of volumetric measures, especially of the basal ganglia, as outcome measures in future clinical trials in pre-HD. Results may also assist investigators in selecting the most appropriate measures for treatment trials that target specific clinical features or regions of neuropathology.
Keywords: Huntington disease, magnetic resonance imaging, cognitive, psychiatric, motor
DOI: 10.3233/JHD-130076
Journal: Journal of Huntington's Disease, vol. 2, no. 4, pp. 477-489, 2013
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl